SLC1A5 and cancer: It is confirmed that Gln is taken up by SLC1A5/ASCT2 in cancer cells and enters into the glutaminolysis pathway; thereby, glutamate is formed and can be used in GSH synthesis (Bhutia and Ganapathy, 2016[6]; Yang et al., 2017[86]).